Dr. Anand graduated with a Ph.D. in Immunology from Johns Hopkins University in 2007 followed by postdoctoral training at the Moores Cancer Center at UC San Diego. He joined OHSU in 2014 to establish a research program that is focused on understanding the tumor microenvironment. His lab recently discovered a role for a DNA repair enzyme in suppressing the immune responses in different preclinical tumor models. Ongoing efforts in his lab have identified small molecule inhibitors to target specific DNA repair enzymes with the goal of enhancing immune responses to tumors. Discovery work in the Anand lab is supported by two NIH R01 grants and an innovative research grant from the American Heart Association. Dr. Anand has published 26 peer-reviewed papers and holds two issued patents.